This websites contains videos from YouTube. This company uses
cookies (third party cookies). If you do not want them to use these
cookies, you can indicate so here. However, this does mean that you
will not be able to watch videos on this website. We also make use
of our own cookies in order to improve our website. We don't share
our data with other parties. Which cookies are involved?
user experience. If you do not want to accept these cookies,
indicate so here. Which cookies are involved?
Researchers at the Netherlands Cancer Institute have discovered
a new location of the salivary glands. This is potentially great
news for patients with head and neck tumors: radiation oncologists
will now be able to circumvent this area to avoid potential
complications. On Friday October 16th they publish their
research in Radiotherapy & Oncology, together with colleagues
from Amsterdam UMC, UMCG and UMC Utrecht.
Neo-adjuvant immunotherapy combination effective for non-metastatic bladder cancer
This week, researchers at the Netherlands Cancer Institute
published the results
of the NABUCCO study in scientific journal Nature Medicine. In this
publication, they show that neoadjuvant immunotherapy using a
combination of two drugs (nivolumab and ipilimumab) is a feasible
treatment for bladder cancer without harming the scheduled
resection, and shows promising results.